Arcellx (ACLX) Depreciation & Amortization (CF) (2021 - 2025)

Arcellx's (ACLX) quarterly Depreciation & Amortization (CF) came in at $1.6 million in Q4 2025, down 8.27% year-on-year from $1.8 million in Q4 2024, and down 10.96% quarter-over-quarter from $1.8 million in Q3 2025.

Arcellx (ACLX) Depreciation & Amortization (CF) (2021 - 2025) Analysis & Trends

Arcellx's Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $1.6 million for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 8.27% year-over-year to $1.6 million in Q4 2025; TTM through Dec 2025 was $6.7 million, a 28.72% increase from a year earlier, with the FY2025 full-year figure at $6.7 million, up 28.72% from the prior year.
  • Depreciation & Amortization (CF) slipped to $1.6 million in Q4 2025 per ACLX's latest filing, from $1.8 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.8 million in Q3 2025 and bottomed at $207000.0 in Q1 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $443000.0 (2023), against an average of $813400.0.
  • Across the five-year window, Depreciation & Amortization (CF) soared 198.43% in 2024 and slipped 8.27% in 2025, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $331000.0 in 2021, then gained by 25.68% to $416000.0 in 2022, then soared by 73.56% to $722000.0 in 2023, then surged by 147.78% to $1.8 million in 2024, then slipped by 8.27% to $1.6 million in 2025.
  • Per Business Quant, the three latest ACLX Depreciation & Amortization (CF) figures stand at $1.6 million (Q4 2025), $1.8 million (Q3 2025), and $1.6 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 1.64 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.64 Mn
Dec 31, 2025 1.64 Mn
Sep 30, 2025 1.84 Mn
Sep 30, 2025 1.84 Mn
Jun 30, 2025 1.62 Mn
Jun 30, 2025 1.62 Mn
Mar 31, 2025 1.58 Mn
Mar 31, 2025 1.58 Mn
Dec 31, 2024 1.79 Mn
Dec 31, 2024 1.79 Mn
Sep 30, 2024 1.33 Mn
Sep 30, 2024 1.33 Mn
Jun 30, 2024 1.24 Mn
Jun 30, 2024 1.24 Mn
Mar 31, 2024 826,000.00
Mar 31, 2024 826,000.00
Dec 31, 2023 722,000.00
Dec 31, 2023 722,000.00
Sep 30, 2023 447,000.00
Sep 30, 2023 447,000.00